Board Meeting22 Oct 2026, 07:00 pm
Entero Healthcare Board Meeting on Nov 4 to Review Q2 Results
AI Summary
Entero Healthcare Solutions Ltd has announced that its Board of Directors will convene on November 4, 2026. The primary agenda item is to consider, approve, and take on record the Unaudited Standalone and Consolidated Financial Results for the quarter ended September 30, 2026, along with the Limited Review Report. The trading window for company securities remains closed for designated persons from October 1, 2026, until 48 hours after the results are declared.
Key Highlights
- Board meeting scheduled for November 4, 2026.
- To approve unaudited standalone and consolidated financial results.
- Limited Review Report for Q2 FY27 to be considered.
- Trading window closure in effect until results announcement.
Price Impact
More from ENTERO